Mutations in PDGFRB Cause Autosomal-Dominant Infantile Myofibromatosis
Author(s) -
John A. Martignetti,
Lifeng Tian,
Dong Li,
Maria Celeste M. Ramirez,
Olga CamachoVanegas,
Sandra Catalina Camacho,
Yiran Guo,
Dina J. Zand,
Audrey M. Bernstein,
Sandra K. Masur,
Chong Ae Kim,
F. George Otieno,
Cuiping Hou,
Nada Abdelmagid,
Ben Tweddale,
Denise W. Metry,
JeanChristophe Fournet,
Eniko Papp,
Elizabeth McPherson,
Carrie Zabel,
Guy Vaksmann,
Cyril Morisot,
Brendan J. Keating,
Patrick Sleiman,
Jeffrey A. Cleveland,
David B. Everman,
Elaine H. Zackai,
Hákon Hákonarson
Publication year - 2013
Publication title -
the american journal of human genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.661
H-Index - 302
eISSN - 1537-6605
pISSN - 0002-9297
DOI - 10.1016/j.ajhg.2013.04.024
Subject(s) - pdgfrb , exome sequencing , genetics , biology , mutation , gene , medicine , cancer research
Infantile myofibromatosis (IM) is a disorder of mesenchymal proliferation characterized by the development of nonmetastasizing tumors in the skin, muscle, bone, and viscera. Occurrence within families across multiple generations is suggestive of an autosomal-dominant (AD) inheritance pattern, but autosomal-recessive (AR) modes of inheritance have also been proposed. We performed whole-exome sequencing (WES) in members of nine unrelated families clinically diagnosed with AD IM to identify the genetic origin of the disorder. In eight of the families, we identified one of two disease-causing mutations, c.1978C>A (p.Pro660Thr) and c.1681C>T (p.Arg561Cys), in PDGFRB. Intriguingly, one family did not have either of these PDGFRB mutations but all affected individuals had a c.4556T>C (p.Leu1519Pro) mutation in NOTCH3. Our studies suggest that mutations in PDGFRB are a cause of IM and highlight NOTCH3 as a candidate gene. Further studies of the crosstalk between PDGFRB and NOTCH pathways may offer new opportunities to identify mutations in other genes that result in IM and is a necessary first step toward understanding the mechanisms of both tumor growth and regression and its targeted treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom